Episode 93 Multistem, A Game Changer – Interview With Gil Van Bokkelen, CEO of Athersys
Dr Gil Van Bokkelen, Ph.D., CEO, Athersys, Inc
Multistem®, a drug-like cell therapy to treat stroke with adult stem cells is developed by Athersys ...More
Episode 92: A Journey of Inspiration – Dr Paul Coyne and Inspiren
At age 26, Paul Coyne had to leave Goldman Sachs because of the residual of the stroke that happened to him.
Michael Wang, Co Founder of Inspiren and ...More